Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

3.
4.

Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.

Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, Menter A, Baumann L, Wieder JJ, Jarratt MM, Pariser D, Martin D, Weiss J, Shavin J, Ramirez N.

Cutis. 2003 Jul;72(1):67-72.

PMID:
12889718
5.
6.

Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.

Tirado-Sánchez A, Santamaría-Román A, Ponce-Olivera RM.

Int J Dermatol. 2009 Aug;48(8):893-5. doi: 10.1111/j.1365-4632.2009.04105.x.

PMID:
19659872
7.

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.

Makino ET, Herndon JH, Sigler ML, Gotz V, Garruto J, Mehta RC.

J Drugs Dermatol. 2012 Dec;11(12):1478-82.

PMID:
23377519
8.

Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.

Khemis A, Kaiafa A, Queille-Roussel C, Duteil L, Ortonne JP.

Br J Dermatol. 2007 May;156(5):997-1004. Epub 2007 Mar 28.

PMID:
17388924
9.
10.

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.

Makino ET, Mehta RC, Garruto J, Gotz V, Sigler ML, Herndon JH.

J Drugs Dermatol. 2013 Mar;12(3):s21-6.

PMID:
23545929
13.
14.

Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.

Grimes PE, Bhawan J, Guevara IL, Colón LE, Johnson LA, Gottschalk RW, Pandya AG.

J Am Acad Dermatol. 2010 Jun;62(6):962-7. doi: 10.1016/j.jaad.2009.06.067. Epub 2010 Apr 15.

PMID:
20398959
16.

Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.

Nanda S, Grover C, Reddy BS.

Dermatol Surg. 2004 Mar;30(3):385-8; discussion 389.

PMID:
15008866
17.

The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.

Adalatkhah H, Sadeghi-Bazargani H.

Drug Des Devel Ther. 2015 Aug 4;9:4219-25. doi: 10.2147/DDDT.S80713. eCollection 2015.

18.

Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.

Rendon M, Cardona LM, Bussear EW, Benitez AL, Colón LE, Johnson LA.

Cutis. 2008 Nov;82(5):372-8.

PMID:
19090343
19.

Community-based trial of a triple-combination agent for the treatment of facial melasma.

Grimes P, Kelly AP, Torok H, Willis I.

Cutis. 2006 Mar;77(3):177-84.

PMID:
16610738
20.

Novel skin brightener used as monotherapy for moderate melasma in skin of color.

Grimes PE.

J Drugs Dermatol. 2014 Mar;13(3):364-6.

PMID:
24595584

Supplemental Content

Support Center